Thomson Peter G. (CIK 0001779120)

Latest company ownership

FULC - Fulcrum Therapeutics, Inc.

Role: VP Finance & Accounting

Shares held

40,000

Last filed at

Jan 21, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 28, 2021	Jun 29, 2021	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Buy	91.3	+2,300	100.00%	✗	$20.7K
Feb 22, 2021	Feb 24, 2021	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Sell	15.0	-5,000	-24.74%	✓	$73.6K
Jan 21, 2021	Jan 25, 2021	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Sell	10.0	-6,607	-30.28%	✓	$92.5K
May 11, 2020	May 12, 2020	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Sell	10.0	-7,500	-26.25%	✓	$120K
Feb 24, 2020	Feb 26, 2020	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Sell	25.0	-5,000	-14.89%	✓	$84.2K
Jan 23, 2020	Jan 27, 2020	Fulcrum Therapeutics, Inc.	VP Finance & Accounting	Sell	25.0	-5,000	-12.96%	✓	$86.1K